Home / Human Healthcare / Nutraceuticals / Binthin
Binthin

Overweight and obesity has reached epidemic proportions globally. According to the recent estimates in 2010, approximately 1.0 billion adults were overweight and 475 million were obese. Increasing prevalence of obesity, seen both in the developed and developing countries, is primarily driven by imbalanced diets and sedentary lifestyles. The rising prevalence of overweight and obesity in India too is largely due to an increase in energy intake, owing to increased purchasing power and availability of high fat, energy-dense foods, along with reduction in the energy expenditure consequent to urbanization and mechanization.

Obesity is an important factor for the development of metabolic syndrome (MS), type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD); conditions increasingly observed in Asian Indians. Rapidly increasing prevalence of T2DM in India may be substantially contributed by generalized and abdominal obesity. Increasingly, it has become apparent that generalized and abdominal obesity is prevalent in Asian Indian women. Consequently, these women have a clustering of risk factors (hypertension, dyslipidemia and MS), equivalent to or more often than men. It appears that this subset of Indian population is particularly susceptible to develop a cluster of these diseases.

The alarming rise in obesity during the past few decades has led physicians, parents, life-style specialists and individuals to pay increasing attention to changes in the nutritional status of themselves and and their families. Scrutiny has been focused primarily on four culprits, namely sugar, fat, junk-food, aerated colas, sedentary lifestyles, inactivity and more recently television. Can a parallel be drawn between the exponential rise in sales of junk food, aerated colas and electronic screens of all kinds, including televisions, game consoles and hand held - electronic games and the increase in obesity ? Surveys conducted have shown that prevalence of obesity, defined as a body mass index (BMI) of greater than 30 kg/m2, is increasing, among women, men and adolescents.

The active nutraceutical ingredients, in combination can be loaded into a single capsule, capable of exerting multiple actions, with least adverse effects, thereby improving patient compliance battling obesity. The ease of administration and the availability of these medications, with scientific and documented evidence, has encouraged a number of healthcare givers, physicians and life-style specialists to try out these medications to individuals who are seeking treatment for obesity.

  Copyright © 2014 Sanzyme. All rights reserved.